 | • レポートコード：D0GIR-02547 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：サービス、ソフトウェア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、希少バイオマーカー検体収集 ・安定化の世界市場を広く調査・分析し、今後の市場展望をまとめております。希少バイオマーカー検体収集 ・安定化の種類別市場規模（循環細胞フリーDNA（ccfDNA）、循環腫瘍細胞（CTC）、エキソソーム/細胞外小胞、循環細胞フリーRNA（ccfRNA）/ miRNA）、用途別市場規模（研究、診断）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Miltenyi Biotec、Roche、Veridex、QIAGEN、STRECK, INC.、Creatv MicroTech、Genetix、Creative-Bioarray、Amgen ・地域別グローバル市場分析 2015年-2020年 ・希少バイオマーカー検体収集 ・安定化の北米市場（アメリカ、カナダ、メキシコ） ・希少バイオマーカー検体収集 ・安定化のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・希少バイオマーカー検体収集 ・安定化のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・希少バイオマーカー検体収集 ・安定化の南米市場（ブラジル、アルゼンチン） ・希少バイオマーカー検体収集 ・安定化の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：循環細胞フリーDNA（ccfDNA）、循環腫瘍細胞（CTC）、エキソソーム/細胞外小胞、循環細胞フリーRNA（ccfRNA）/ miRNA ・用途別分析：研究、診断 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Rare Biomarkers Specimen Collection And Stabilization market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Rare Biomarkers Specimen Collection And Stabilization sales will be xx in 2020 from Rare Biomarkers Specimen Collection And Stabilization million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Rare Biomarkers Specimen Collection And Stabilization market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Rare Biomarkers Specimen Collection And Stabilization industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Rare Biomarkers Specimen Collection And Stabilization and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Rare Biomarkers Specimen Collection And Stabilization market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rare Biomarkers Specimen Collection And Stabilization market has been segmented into:
Circulating Cell Free DNA (ccfDNA)
Circulating Tumor Cells (CTCs)
Exosomes/Extracellular Vesicles
Circulating Cell Free RNA (ccfRNA) / miRNA
By Application, Rare Biomarkers Specimen Collection And Stabilization has been segmented into:
Research
Diagnostics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rare Biomarkers Specimen Collection And Stabilization market presented in the report. This section sheds light on the sales growth of different regional and country-level Rare Biomarkers Specimen Collection And Stabilization markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rare Biomarkers Specimen Collection And Stabilization market.
The report offers in-depth assessment of the growth and other aspects of the Rare Biomarkers Specimen Collection And Stabilization market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Rare Biomarkers Specimen Collection And Stabilization Market Share Analysis
Rare Biomarkers Specimen Collection And Stabilization competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rare Biomarkers Specimen Collection And Stabilization sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rare Biomarkers Specimen Collection And Stabilization sales, revenue and market share for each player covered in this report.
The major players covered in Rare Biomarkers Specimen Collection And Stabilization are:
Miltenyi Biotec
Roche
Veridex
QIAGEN
STRECK, INC.
Creatv MicroTech
Genetix
Creative-Bioarray
Amgen
Among other players domestic and global, Rare Biomarkers Specimen Collection And Stabilization market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Rare Biomarkers Specimen Collection And Stabilization Market Overview
1.1 Product Overview and Scope of Rare Biomarkers Specimen Collection And Stabilization
1.2 Classification of Rare Biomarkers Specimen Collection And Stabilization by Type
1.2.1 Global Rare Biomarkers Specimen Collection And Stabilization Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Type in 2019
1.2.3 Circulating Cell Free DNA (ccfDNA)
1.2.4 Circulating Tumor Cells (CTCs)
1.2.5 Exosomes/Extracellular Vesicles
1.2.6 Circulating Cell Free RNA (ccfRNA) / miRNA
1.3 Global Rare Biomarkers Specimen Collection And Stabilization Market by Application
1.3.1 Overview: Global Rare Biomarkers Specimen Collection And Stabilization Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research
1.3.3 Diagnostics
1.4 Global Rare Biomarkers Specimen Collection And Stabilization Market by Regions
1.4.1 Global Rare Biomarkers Specimen Collection And Stabilization Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Rare Biomarkers Specimen Collection And Stabilization (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Rare Biomarkers Specimen Collection And Stabilization Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Rare Biomarkers Specimen Collection And Stabilization Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rare Biomarkers Specimen Collection And Stabilization Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Rare Biomarkers Specimen Collection And Stabilization Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rare Biomarkers Specimen Collection And Stabilization Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Rare Biomarkers Specimen Collection And Stabilization Industry Impact
1.5.1 COVID-19 Potential Implications for the Rare Biomarkers Specimen Collection And Stabilization
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Rare Biomarkers Specimen Collection And Stabilization
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Miltenyi Biotec
2.1.1 Miltenyi Biotec Details
2.1.2 Miltenyi Biotec Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Miltenyi Biotec SWOT Analysis
2.1.4 Miltenyi Biotec Product and Services
2.1.5 Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Rare Biomarkers Specimen Collection And Stabilization Revenue, Gross Margin and Market Share (2018-2019)
2.3 Veridex
2.3.1 Veridex Details
2.3.2 Veridex Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Veridex SWOT Analysis
2.3.4 Veridex Product and Services
2.3.5 Veridex Rare Biomarkers Specimen Collection And Stabilization Revenue, Gross Margin and Market Share (2018-2019)
2.4 QIAGEN
2.4.1 QIAGEN Details
2.4.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 QIAGEN SWOT Analysis
2.4.4 QIAGEN Product and Services
2.4.5 QIAGEN Rare Biomarkers Specimen Collection And Stabilization Revenue, Gross Margin and Market Share (2018-2019)
2.5 STRECK, INC.
2.5.1 STRECK, INC. Details
2.5.2 STRECK, INC. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 STRECK, INC. SWOT Analysis
2.5.4 STRECK, INC. Product and Services
2.5.5 STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Revenue, Gross Margin and Market Share (2018-2019)
2.6 Creatv MicroTech
2.6.1 Creatv MicroTech Details
2.6.2 Creatv MicroTech Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Creatv MicroTech SWOT Analysis
2.6.4 Creatv MicroTech Product and Services
2.6.5 Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genetix
2.7.1 Genetix Details
2.7.2 Genetix Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Genetix SWOT Analysis
2.7.4 Genetix Product and Services
2.7.5 Genetix Rare Biomarkers Specimen Collection And Stabilization Revenue, Gross Margin and Market Share (2018-2019)
2.8 Creative-Bioarray
2.8.1 Creative-Bioarray Details
2.8.2 Creative-Bioarray Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Creative-Bioarray SWOT Analysis
2.8.4 Creative-Bioarray Product and Services
2.8.5 Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Amgen SWOT Analysis
2.9.4 Amgen Product and Services
2.9.5 Amgen Rare Biomarkers Specimen Collection And Stabilization Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Rare Biomarkers Specimen Collection And Stabilization Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Rare Biomarkers Specimen Collection And Stabilization Players Market Share
3.2.2 Top 10 Rare Biomarkers Specimen Collection And Stabilization Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Rare Biomarkers Specimen Collection And Stabilization Revenue and Market Share by Regions
4.2 North America Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
4.3 Europe Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
4.5 South America Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
5 North America Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries
5.1 North America Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries (2015-2020)
5.2 USA Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
5.3 Canada Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
5.4 Mexico Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
6 Europe Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries
6.1 Europe Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries (2015-2020)
6.2 Germany Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
6.3 UK Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
6.4 France Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
6.5 Russia Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
6.6 Italy Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries
7.1 Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries (2015-2020)
7.2 China Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
7.3 Japan Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
7.4 Korea Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
7.5 India Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
8 South America Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries
8.1 South America Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries (2015-2020)
8.2 Brazil Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
8.3 Argentina Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Rare Biomarkers Specimen Collection And Stabilization by Countries
9.1 Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries (2015-2020)
9.2 Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
9.3 UAE Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
9.4 Egypt Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
9.5 South Africa Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Rare Biomarkers Specimen Collection And Stabilization Revenue and Market Share by Type (2015-2020)
10.2 Global Rare Biomarkers Specimen Collection And Stabilization Market Forecast by Type (2019-2024)
10.3 Circulating Cell Free DNA (ccfDNA) Revenue Growth Rate (2015-2025)
10.4 Circulating Tumor Cells (CTCs) Revenue Growth Rate (2015-2025)
10.5 Exosomes/Extracellular Vesicles Revenue Growth Rate (2015-2025)
10.6 Circulating Cell Free RNA (ccfRNA) / miRNA Revenue Growth Rate (2015-2025)
11 Global Rare Biomarkers Specimen Collection And Stabilization Market Segment by Application
11.1 Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Application (2015-2020)
11.2 Rare Biomarkers Specimen Collection And Stabilization Market Forecast by Application (2019-2024)
11.3 Research Revenue Growth (2015-2020)
11.4 Diagnostics Revenue Growth (2015-2020)
12 Global Rare Biomarkers Specimen Collection And Stabilization Market Size Forecast (2021-2025)
12.1 Global Rare Biomarkers Specimen Collection And Stabilization Market Size Forecast (2021-2025)
12.2 Global Rare Biomarkers Specimen Collection And Stabilization Market Forecast by Regions (2021-2025)
12.3 North America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Forecast (2021-2025)
12.4 Europe Rare Biomarkers Specimen Collection And Stabilization Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue Market Forecast (2021-2025)
12.6 South America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Rare Biomarkers Specimen Collection And Stabilization Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rare Biomarkers Specimen Collection And Stabilization by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Rare Biomarkers Specimen Collection And Stabilization Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Miltenyi Biotec Corporate Information, Location and Competitors
Table 7. Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Major Business
Table 8. Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Total Revenue (USD Million) (2017-2018)
Table 9. Miltenyi Biotec SWOT Analysis
Table 10. Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Product and Solutions
Table 11. Miltenyi Biotec Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Roche Corporate Information, Location and Competitors
Table 13. Roche Rare Biomarkers Specimen Collection And Stabilization Major Business
Table 14. Roche Rare Biomarkers Specimen Collection And Stabilization Total Revenue (USD Million) (2018-2019)
Table 15. Roche SWOT Analysis
Table 16. Roche Rare Biomarkers Specimen Collection And Stabilization Product and Solutions
Table 17. Roche Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Veridex Corporate Information, Location and Competitors
Table 19. Veridex Rare Biomarkers Specimen Collection And Stabilization Major Business
Table 20. Veridex Rare Biomarkers Specimen Collection And Stabilization Total Revenue (USD Million) (2017-2018)
Table 21. Veridex SWOT Analysis
Table 22. Veridex Rare Biomarkers Specimen Collection And Stabilization Product and Solutions
Table 23. Veridex Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. QIAGEN Corporate Information, Location and Competitors
Table 25. QIAGEN Rare Biomarkers Specimen Collection And Stabilization Major Business
Table 26. QIAGEN Rare Biomarkers Specimen Collection And Stabilization Total Revenue (USD Million) (2017-2018)
Table 27. QIAGEN SWOT Analysis
Table 28. QIAGEN Rare Biomarkers Specimen Collection And Stabilization Product and Solutions
Table 29. QIAGEN Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. STRECK, INC. Corporate Information, Location and Competitors
Table 31. STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Major Business
Table 32. STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Total Revenue (USD Million) (2017-2018)
Table 33. STRECK, INC. SWOT Analysis
Table 34. STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Product and Solutions
Table 35. STRECK, INC. Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Creatv MicroTech Corporate Information, Location and Competitors
Table 37. Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Major Business
Table 38. Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Total Revenue (USD Million) (2017-2018)
Table 39. Creatv MicroTech SWOT Analysis
Table 40. Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Product and Solutions
Table 41. Creatv MicroTech Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Genetix Corporate Information, Location and Competitors
Table 43. Genetix Rare Biomarkers Specimen Collection And Stabilization Major Business
Table 44. Genetix Rare Biomarkers Specimen Collection And Stabilization Total Revenue (USD Million) (2017-2018)
Table 45. Genetix SWOT Analysis
Table 46. Genetix Rare Biomarkers Specimen Collection And Stabilization Product and Solutions
Table 47. Genetix Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Creative-Bioarray Corporate Information, Location and Competitors
Table 49. Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Major Business
Table 50. Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Total Revenue (USD Million) (2017-2018)
Table 51. Creative-Bioarray SWOT Analysis
Table 52. Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Product and Solutions
Table 53. Creative-Bioarray Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Amgen Corporate Information, Location and Competitors
Table 55. Amgen Rare Biomarkers Specimen Collection And Stabilization Major Business
Table 56. Amgen Rare Biomarkers Specimen Collection And Stabilization Total Revenue (USD Million) (2017-2018)
Table 57. Amgen SWOT Analysis
Table 58. Amgen Rare Biomarkers Specimen Collection And Stabilization Product and Solutions
Table 59. Amgen Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Players (2015-2020)
Table 61. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Share by Players (2015-2020)
Table 62. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Regions (2015-2020)
Table 64. North America Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries (2015-2020)
Table 65. North America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries (2015-2020)
Table 66. Europe Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Rare Biomarkers Specimen Collection And Stabilization Revenue by Countries (2015-2020)
Table 69. South America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries (2015-2020)
Table 72. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) by Type (2015-2020)
Table 73. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Share by Type (2015-2020)
Table 74. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Forecast by Type (2021-2025)
Table 75. Global Rare Biomarkers Specimen Collection And Stabilization Revenue by Application (2015-2020)
Table 76. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Share by Application (2015-2020)
Table 77. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Forecast by Application (2021-2025)
Table 78. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Rare Biomarkers Specimen Collection And Stabilization Picture
Figure 2. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Type in 2019
Figure 3. Circulating Cell Free DNA (ccfDNA) Picture
Figure 4. Circulating Tumor Cells (CTCs) Picture
Figure 5. Exosomes/Extracellular Vesicles Picture
Figure 6. Circulating Cell Free RNA (ccfRNA) / miRNA Picture
Figure 7. Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Application in 2019
Figure 8. Research Picture
Figure 9. Diagnostics Picture
Figure 10. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share in 2019
Figure 19. Global Top 10 Players Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Regions (2015-2020)
Figure 23. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Regions in 2018
Figure 24. North America Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 25. Europe Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 27. South America Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 29. North America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries (2015-2020)
Figure 30. North America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries in 2019
Figure 31. USA Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 32. Canada Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 34. Europe Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries in 2019
Figure 36. Germany Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 37. UK Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 38. France Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 39. Russia Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 40. Italy Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries in 2019
Figure 43. China Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 44. Japan Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 45. Korea Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 46. India Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 48. South America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries (2015-2020)
Figure 49. South America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries in 2019
Figure 50. Brazil Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 55. UAE Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Rare Biomarkers Specimen Collection And Stabilization Revenue and Growth Rate (2015-2020)
Figure 58. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Share by Type (2015-2020)
Figure 59. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Share by Type in 2019
Figure 60. Global Rare Biomarkers Specimen Collection And Stabilization Market Share Forecast by Type (2021-2025)
Figure 61. Global Circulating Cell Free DNA (ccfDNA) Revenue Growth Rate (2015-2020)
Figure 62. Global Circulating Tumor Cells (CTCs) Revenue Growth Rate (2015-2020)
Figure 63. Global Exosomes/Extracellular Vesicles Revenue Growth Rate (2015-2020)
Figure 64. Global Circulating Cell Free RNA (ccfRNA) / miRNA Revenue Growth Rate (2015-2020)
Figure 65. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Share by Application (2015-2020)
Figure 66. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Share by Application in 2019
Figure 67. Global Rare Biomarkers Specimen Collection And Stabilization Market Share Forecast by Application (2021-2025)
Figure 68. Global Research Revenue Growth Rate (2015-2020)
Figure 69. Global Diagnostics Revenue Growth Rate (2015-2020)
Figure 70. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Rare Biomarkers Specimen Collection And Stabilization Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Rare Biomarkers Specimen Collection And Stabilization Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Forecast (2021-2025)
Figure 74. Europe Rare Biomarkers Specimen Collection And Stabilization Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Revenue Market Forecast (2021-2025)
Figure 76. South America Rare Biomarkers Specimen Collection And Stabilization Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Rare Biomarkers Specimen Collection And Stabilization Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
土壌安定化の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Soil Stabilization market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.6% in the forecast period of 2020 to 2025 and will expected to reach USD 22450 million by 2025, from USD 20300 million in 2019. The Soil Stabilization …- PARP阻害剤バイオマーカーサービスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The PARP Inhibitor Biomarkers Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- カテーテル安定化装置/カテーテル固定装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Catheter Stabilization Devices/Catheter Securement Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.1% in the forecast period of 2020 to 2025 and will expected to reach USD 1086 million by 2025, from USD 925.9 m…
- 医療バイオマーカーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Medical Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 予測バイオマーカーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Predictive Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Predictive Biomarkers m…